The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.1048259
Abstract: Introduction: Cannabidiol (CBD) has been clinically approved for intractable epilepsies, offering hope that novel anticonvulsants in the phytocannabinoid class might be developed. Looking beyond CBD, we have recently reported that a series of biosynthetic precursor… read more here.
Keywords: anticonvulsant phytocannabinoids; type channels; cbdva inhibit; cbgva cbdva ... See more keywords